Pleyer, L., Leisch, M., Kourakli, A., Padron, E., Maciejewski, J. P., Xicoy Cirici, B., Kaivers, J., Ungerstedt, J., Heibl, S., Patiou, P., Hunter, A. M., Mora, E., Geissler, K., Dimou, M., Jimenez Lorenzo, M., Melchardt, T., Egle, A., Viniou, A., Patel, B. J., Arnan, M., Valent, P., Roubakis, C., Bernal del Castillo, T., Galanopoulos, A., Calabuig Muñoz, M., Bonadies, N., Medina de Almeida, A., Cermak, J., Jerez, A., Montoro, M. J., Cortés, A., Avendaño Pita, A., Lopez Andrade, B., Hellstroem-Lindberg, E., Germing, U., Sekeres, M. A., List, A. F., Symeonidis, A., Sanz, G. F., Larcher-Senn, J., & Greil, R. (2021). outcomes of patients with chronic myelomonocytic leukaemia treated with non-curative therapies: a retrospective cohort study. Lancet, 8(2), e135–e148. http://access.bl.uk/ark:/81055/vdc_100160127608.0x00000d